Skip to Content
Merck
CN

Inhibitors of the FEZ-1 metallo-beta-lactamase.

Bioorganic & medicinal chemistry letters (2006-12-13)
Benoît M R Liénard, Louise E Horsfall, Moreno Galleni, Jean-Marie Frère, Christopher J Schofield
ABSTRACT

Metallo-beta-lactamases (MBLs) catalyze the hydrolysis of beta-lactams including penicillins, cephalosporins and carbapenems. Starting from benzohydroxamic acid (1) structure-activity studies led to the identification of selective inhibitors of the FEZ-1 MBL, e.g., 2,5-substituted benzophenone hydroxamic acid 17 has a K(i) of 6.1+/-0.7microM against the FEZ-1 MBL but does not significantly inhibit the IMP-1, BcII, CphA or L1 MBLs.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Benzhydroxamic acid, 99%